Related Experiment Video
Updated: May 4, 2026

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
The dendritic hypothesis for Alzheimer's disease pathophysiology
J Nicholas Cochran1, Alicia M Hall1, Erik D Roberson1
1Center for Neurodegeneration and Experimental Therapeutics, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, United States.
Alzheimer's disease (AD) pathogenesis involves neuronal dendrites, supporting a "dendritic hypothesis." Key factors like amyloid-beta, tau, and genetics impact dendritic structure and function, offering therapeutic targets.
Area of Science:
- Neuroscience
- Pathology
- Genetics
Background:
- Neuronal dendrites are increasingly recognized as critical sites for Alzheimer's disease (AD) pathogenesis.
- Existing research supports a synaptic hypothesis, but dendritic processes offer a complementary perspective.
Purpose of the Study:
- To detail dendritic neuropathology in Alzheimer's disease.
- To examine the impact of amyloid-beta (Aβ), tau, and genetic risk factors on dendritic structure and function.
- To explore mechanisms linking dendritic dysfunction to AD progression and identify therapeutic targets.
Main Methods:
- Review and synthesis of existing evidence on dendritic changes in AD.
- Analysis of how specific AD-related molecules (Aβ, tau) and genetic factors influence dendritic morphology and physiology.
- Conceptual framework development for dendritic mechanisms in AD pathogenesis.
Main Results:
- Converging evidence implicates dendritic alterations in AD.
- Aβ, tau, and genetic risk factors demonstrably affect dendritic structure and function.
- Specific molecular and cellular mechanisms driving dendritic pathology in AD are proposed.
Conclusions:
- The "dendritic hypothesis" of AD provides a framework for understanding disease mechanisms.
- Targeting dendritic integrity and function presents a promising avenue for developing novel AD therapeutics.
- Further research into these dendritic mechanisms can guide the development of disease-modifying treatments.
More Related Videos
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia l: Introduction
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Parkinson Disease ll: Pathophysiology